NOVOLOG (Novo Nordisk)
Welcome to the PulseAid listing for the NOVOLOG drug offered from Novo Nordisk. This Insulin [Chemical/Ingredient],Insulin Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novo Nordisk |
| NON-PROPRIETARY NAME: | insulin aspart |
| SUBSTANCE NAME: | INSULIN ASPART |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
| ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2001-08-27 |
| END MARKETING DATE: | 0000-00-00 |
NOVOLOG HUMAN PRESCRIPTION DRUG Details:
| Item Description | NOVOLOG from Novo Nordisk |
| LABELER NAME: | Novo Nordisk |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100([iU]/mL) |
| START MARKETING DATE: | 2001-08-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0169-3303_4c2ff137-76d4-4e7b-bc43-d5213052f4c7 |
| PRODUCT NDC: | 0169-3303 |
| APPLICATION NUMBER: | NDA020986 |
Other INSULIN ASPART Pharmaceutical Manufacturers / Labelers:
